Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76611 | Xeris Biopharma Holdings Inc (2B30.BE) | XBER | US | 2023-12-31 | 2 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 76612 | Xeris Biopharma Holdings Inc (2B30.F) | XFRA | US | 2023-12-31 | 2 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 76613 | Xeris Biopharma Holdings Inc (2B30.F) | US | 2021-12-31 | 1 year ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | |
| 76614 | Xeris Biopharma Holdings Inc (2B30.MU) | XMUN | US | 2023-12-31 | 2 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 76615 | Xeris Biopharma Holdings Inc (2B30.SG) | XSTU | US | 2023-12-31 | 2 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 76616 | Xeris Biopharma Holdings Inc (2B30.TG) | XGAT | US | 2023-12-31 | 3 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 76617 | Xeris Pharmaceuticals Inc (2B3.BE) | 2020-12-31 | 2 years ago | USD | 0.00 | 0.00 | 0.00% | 0.45 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 76618 | Xeris Pharmaceuticals Inc (2B3.F) | 2020-12-31 | 2 years ago | USD | 0.00 | 0.00 | 0.00% | 0.45 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 76619 | Xeris Pharmaceuticals Inc (2B3.MU) | 2020-12-31 | 2 years ago | USD | 0.00 | 0.00 | 0.00% | 0.45 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 76620 | Xeris Pharmaceuticals Inc (2B3.SG) | 2020-12-31 | 2 years ago | USD | 0.00 | 0.00 | 0.00% | 0.45 | 0.00% | Ungraded | 0.00 | 0.00% |